NR6A1 and prostate carcinoma: Recent research showed that nuclear receptor subfamily 6, group A, member 1 (NR6A1) regulates lipid metabolism of HepG2 cells, and the positive expression of NR6A1 is a novel marker of disease progression and aggressiveness in prostate cancer patients [26, 27].